HomeNewsNeuroscience

  • Allergan acquires depression compound from Aptinyx

    • May 24, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New Stem cell based treatment investigated for SPMS

    • May 23, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Recent study identified Brain cells underlying Schizophrenia

    • May 23, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Verge Genomics to generate Single Cell Data from Parkinson’s patients

    • May 22, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • EMA reconfirms the low Benefit risk profile of Zinbryta

    • May 22, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Positive results for AFFITOPE® PD01A in Parkinson’s Disease Patients

    • May 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Pre-market approval of INSIGHTEC’s device, for Parkinson’s disease, submitted to Japanese PMDA

    • May 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • J&J stops trial of BACE for Alzheimer’s disease to enter the list of failed drugs

    • May 19, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • FDA approves Aimovig, first aCGRP drug for preventive treatment of Migraine

    • May 18, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New Alzheimer’s risk genes identified through Big data research

    • May 18, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more